Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE:
LATEST: Ozempic®▼ (semaglutide) for adults living with type 2 diabetes in the UK
Message from Novo Nordisk UK, correct as of 14 June 2023.
Novo Nordisk UK is aware of intermittent stock shortages of Ozempic® ▼(semaglutide) in the UK. Unprecedented levels of demand for this medicine have tested our manufacturing capacity. Whilst we continue to increase our capacity significantly, our present supply does not always meet this excess demand, which has led to intermittent supply which is expected to last into 2024.
The shortage is not because of any safety or quality related concern with Ozempic.
During this shortage period, as per DHSC (Department of Health & Social Care) recommendation, no new patients should be initiated on Ozempic so that available stock can be used for existing patients.
We understand the uncertainty and concern this shortage may cause people living with diabetes. This is not something we are taking lightly, and we are working hard to solve these challenges.
SUB-TYPE:
Alliance Healthcare UK to supply NEBIDO in a solus wholesale agreement with Grünenthal: June 2023
We are pleased to announce that Alliance Healthcare UK is now the only wholesaler to supply NEBIDO to all pharmacies, hospitals and dispensing doctors in the United Kingdom, including Northern Ireland. NEBIDO has been acquired by Grünenthal from Bayer.
Click here for full product details.
SUB-TYPE: CLASS 3 RECALL
Class 3 recall- Medical Oxygen B.P (MEDIGAS OXYGEN B.P)
The Medicines and Healthcare products Regulatory Authority (MHRA) has been made aware that falsified medical oxygen has been provided to several dental practices across the UK. You may have received an email from the Care Quality Commission alerting you to this issue. The source of the supply has been identified as batches provided by Tricodent Limited. An assessment of risk to public health and patient safety has been completed and the risk was found to be low. A criminal investigation into the company that supplied this stock is ongoing. The falsified product in circulation is labelled: Medical Oxygen B.P PL No 04280/0001 MEDIGAS OXYGEN.
MHRA drug alert date 6th June 2023
MHRA Ref: MDR 053-04/23
Pip code | Product description | Supplier | Batch Numbers |
ALLIANCE HEALTHCARE DO NOT STOCK | MEDIGAS OXYGEN | TRICODENT LTD | ALL |
Further Information
Authorised and licensed suppliers can offer advice regarding disposal of falsified cylinders, do not return cylinders to Tricodent Limited. For further information on this issue from the MHRA, please contact MHRA Senior Criminal Enforcement Officer Mark Ling: Mark.Ling@mhra.gov.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE:
World Environment Day 2023
Today is World Environment Day 2023.
This year’s campaign, led by UN Environment Programme, focuses on solutions to plastic pollution.
At Alliance Healthcare UK, we got #DrasticWithPlastic and have reduced more than 60% of single-use plastic secondary packaging, since 2019.
We are working hard to remove single-use plastic altogether and are trialling biodegradable corn starch as an alternative where bags are needed.
Find out more about our ESG campaign by clicking here.
SUB-TYPE:
Alliance Healthcare UK to enter into a new solus wholesale agreement with Coloplast: 06 June 2023
We are pleased to announce that, as of 06 June 2023, Alliance Healthcare UK will become the only wholesaler to supply Coloplast’s Wound Care portfolio to all pharmacies, hospitals, and dispensing doctors in Great Britain. Coloplast’s Chronic portfolio will also be remaining in a solus wholesale agreement for supply in Great Britain with Alliance Healthcare. Alliance Healthcare will continue to supply both product portfolios in Northern Ireland.
Click here for full product details of Coloplast’s Wound Care portfolio.
SUB-TYPE:
Heart Transplant Recipient and Driver Trainer at Alliance Healthcare Competes in 2023 World Transplant Games to raise awareness of Organ Donation
Alliance Healthcare UK has shown its support for team member Fran Middleton with his ambition to raise funds to enable him to compete in the 2023 World Transplant Games, organised by organ donation charity Transplant Sport.
Fran, a driver trainer at Alliance Healthcare UK, took part in the volleyball, pétanque and swimming events at the 2023 British Transplant Games. Fran Middleton, who had a heart transplant in 2018, was joined by six other transplant patients from Royal Papworth Hospital who travelled to Perth in Australia as part of the Great Britain and Northern Ireland squad at the World Transplant Games.
The Games began on 15 April and concluded on 21 April and represent the largest organ donor awareness event in the world. The event brings together teams from 45 countries in 17 different sporting events.
Fran attended the games, arranged by Transplant Sport, a charity that aims to encourage organ donation, recognise the donors and donor family, support transplant recipients and their families, encourage everyone to participate in sport and help them lead a healthy life.
Transplant Sport host the annual British Transplant Games and organises numerous fundraising events throughout the year.
On his involvement in the Transplant Games, Fran said: “Wow, what an incredible experience. I’m so thankful just for the chance to be able to do sport again, but to be selected for the team and to represent GB and NI is mind-blowing.
I’m incredibly proud of my two silver medals in volleyball and pétanque and I’m very happy that my involvement helps spread the positives of organ donation and encourages as many people as possible to share their wishes about donation after death with their families. It really does save lives!”
Alliance Healthcare UK encouraged team members to support by holding a prize draw to help Fran’s fundraising activities to sponsor his trip to the games and support this worthy cause that helps raise awareness for organ donation and the British Transplant Games.
Matt Addison, UK Operations Director at Alliance Healthcare UK said: “We are delighted to have supported Fran to get to the World Transplant Games and very proud that he bought home two silver medals! Fran is a great ambassador for this worthy cause that helps raise awareness for organ donation. We are always eager to support causes that help create healthier and happier futures and congratulate Fran on his incredible achievement.”
SUB-TYPE:
Alliance Healthcare UK to enter into a new wholesale agreement with Neon Healthcare: 1 June 2023
We are pleased to announce that, as of 1 June 2023, Alliance Healthcare UK will become one of the chosen wholesalers to supply selected products of Neon Healthcare to all pharmacies, hospitals, and dispensing doctors in the United Kingdom, including Northern Ireland.
Click below for full product details:
SUB-TYPE:
Alliance Healthcare UK Supports Medicines to Ukraine Campaign
The Medicines to Ukraine pharmacy appeal is led by The Healthcare Distribution Association (HDA), Pharmacists' Defence Association (PDA), and National Pharmacy Association (NPA) in the UK, who are urging pharmacy teams to promote the campaign to customers and members of the public to raise funds.
Alliance Healthcare UK has supported the Medicine to Ukraine campaign through its distribution network; via a coordinated, country-wide poster drop to UK pharmacy stores.
Over 15,000 Medicines to Ukraine posters have been delivered to pharmacies across the UK. The posters are already in pharmacy windows across Europe raising awareness of the campaign.
The Medicines to Ukraine campaign is part of a pan-European effort established by Employed Pharmacists in Europe (EPhEU). The campaign procures and sends specialist hospital medicines that are running low or that are no longer available in Ukraine directly to Ukrainian hospitals that are treating the casualties of the war.
Roughly £220,000 has been raised via the appeal in the UK alone and a total of £3 million has been raised across Europe to date.
Martin Sawer, Executive Director of HDA commented: “Our member companies’ distribution networks ensure a comprehensive, resilient and efficient supply system is always there for community pharmacies, hospitals and dispensing doctors. The Association is delighted that an HDA distributor is making use of its own intensive national network to enable this vital campaign.”
Matt Addison, Operations Director at Alliance Healthcare, said: “Each of the 16,500 pharmacies that we supply each day will play an important role in raising awareness of the Medicines to Ukraine campaign. Alliance Healthcare is fortunate to have an operation ready to help our pharmacy customers activate this important appeal and play its part to help those impacted by the war in Ukraine.”
Alliance Healthcare has previously supported on several similar leaflets drops in support of pharmacy, campaigns including the NHS "Stay Well This Winter" campaign.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Caution in use- Metronidazole 200 mg/5 ml Oral Suspension
Drugsrus Limited has informed the MHRA that a small number of bottles of Metronidazole 200 mg/5 ml Oral Suspension 100ml are leaking from the cap.
MHRA drug alert date: 23rd May 2023
Pip code | Product Description | Affected Batches |
1079342 | METRONIDAZOLE SUSPENSION 200MG/5ML | C20070 C20071 C20072 |
This is a caution in use only we are not accepting stock returns.
Further Information
For more information, medical or supply enquiries, please contact Drugsrus Limited on 020 8423 3800, or email info@drugsrus.co.uk.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 Caution in use- Buccolam 10mg
Orifarm UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in one batch of Buccolam 10mg Oromucosal solution has missing information regarding having to break the seal on the inner container before use.
MHRA drug alert date: 22nd May 2023
Pip code | Product Description | Affected Batches |
ALLIANCE DO NOT STOCK
| BUCCOLAM 10MG
| 620903600 |
This is a caution in use only we are not accepting stock returns.
Further Information
For more information, medical or supply enquiries, please contact 01276 698370, or email uk_enquiries@orifarm.com